JP2010515882A5 - - Google Patents

Download PDF

Info

Publication number
JP2010515882A5
JP2010515882A5 JP2009544931A JP2009544931A JP2010515882A5 JP 2010515882 A5 JP2010515882 A5 JP 2010515882A5 JP 2009544931 A JP2009544931 A JP 2009544931A JP 2009544931 A JP2009544931 A JP 2009544931A JP 2010515882 A5 JP2010515882 A5 JP 2010515882A5
Authority
JP
Japan
Prior art keywords
sleep
disorder
disorders
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009544931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010515882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/000116 external-priority patent/WO2008085888A1/en
Publication of JP2010515882A publication Critical patent/JP2010515882A/ja
Publication of JP2010515882A5 publication Critical patent/JP2010515882A5/ja
Withdrawn legal-status Critical Current

Links

JP2009544931A 2007-01-05 2008-01-04 睡眠関連障害を含むｇａｂａ関連神経学的障害を処置するためのｇタンパク質共役受容体およびその調節因子 Withdrawn JP2010515882A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87879607P 2007-01-05 2007-01-05
PCT/US2008/000116 WO2008085888A1 (en) 2007-01-05 2008-01-04 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders

Publications (2)

Publication Number Publication Date
JP2010515882A JP2010515882A (ja) 2010-05-13
JP2010515882A5 true JP2010515882A5 (https=) 2012-03-08

Family

ID=39472025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544931A Withdrawn JP2010515882A (ja) 2007-01-05 2008-01-04 睡眠関連障害を含むｇａｂａ関連神経学的障害を処置するためのｇタンパク質共役受容体およびその調節因子

Country Status (4)

Country Link
US (1) US20110038850A1 (https=)
EP (1) EP2117577A1 (https=)
JP (1) JP2010515882A (https=)
WO (1) WO2008085888A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106459066B (zh) 2014-04-15 2020-07-07 巴兰斯医疗公司 治疗睡眠过度的方法
JP6195684B2 (ja) 2014-06-03 2017-09-13 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ ピラゾール化合物及びｔ型カルシウムチャンネルブロッカーとしてのそれらの使用
WO2016041892A1 (en) 2014-09-15 2016-03-24 Actelion Pharmaceuticals Ltd Triazole compounds as t-type calcium channel blockers
CN110072521B (zh) 2016-12-16 2022-11-29 爱杜西亚药品有限公司 包含t型钙通道阻断剂的药物组合
MA47409A (fr) 2017-02-06 2019-12-11 Idorsia Pharmaceuticals Ltd Nouveau procédé de synthèse de 1-aryl-1-trifluorométhylcyclopropanes
EP3684463B1 (en) 2017-09-19 2025-05-14 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1310945C (zh) * 1999-11-17 2007-04-18 阿瑞那制药公司 人g蛋白偶联受体的内源形式和非内源形式
WO2005011612A2 (en) * 2003-07-31 2005-02-10 The Research Foundation Of State University Of New York Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
WO2005060625A2 (en) * 2003-12-11 2005-07-07 The Trustees Of Columbia University In The City Of New York Grp receptor-related methods for treating and preventing fear-related disorders
GB0328796D0 (en) * 2003-12-12 2004-01-14 Biofocus Plc Compounds which interact with the G-protein coupled receptor family
JP5774264B2 (ja) * 2005-04-27 2015-09-09 アリーナ ファーマシューティカルズ， インコーポレイテッド 肥満および糖尿病、ならびにそれらに関連する病態の処置のため、ならびに血中ｇｌｐ−１レベルを増大させることによって緩和される病態の処置のための、併用療法

Similar Documents

Publication Publication Date Title
JP2010515882A5 (https=)
JP6855466B2 (ja) Ｌｓｄ１阻害剤に関連するバイオマーカーおよびそれらの使用
JP6012591B2 (ja) β−ＮＧＦに対するアプタマー及びβ−ＮＧＦ介在疾患及び障害の治療におけるその使用
IL290294B2 (en) Oligonucleotides for reduction of pd-l1 expression
CN1083448C (zh) 1-苯基-4-苄基哌嗪化合物多巴胺受体亚型的特异性配体(d4)
WO2017013061A1 (en) Biomarkers associated with lsd1 inhibitors and uses thereof
JP2013503642A5 (https=)
TW201938796A (zh) 使用atr抑制劑治療癌症之方法
CA2902186C (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
JP5537812B2 (ja) Ｍｃｐ−１に結合する核酸
JP2008529536A5 (https=)
RU2012112802A (ru) Диагностика интерферона типа 1
JP2011511804A5 (https=)
JP2005505274A5 (https=)
JP2018537093A (ja) 異所性石灰化障害を治療するための組成物およびそれを使用する方法
JP5822079B2 (ja) 疼痛治療剤
AU2022202688A1 (en) Genetic predictors of a response to treatment with CRHR1 antagonists
CA3120534A1 (en) Oligomeric nucleic acid molecule and use thereof
CN105209438A (zh) 苯氧基乙基二氢-1h-异喹啉化合物
JP4990513B2 (ja) 睡眠障害マーカーおよび睡眠障害治療剤
CN1196784C (zh) 人内皮特异受体基因的启动子及其用途
JP2007521333A5 (https=)
CA2634488A1 (en) Catecholamine regulated protein
JP6103637B2 (ja) 高病原性鳥インフルエンザウイルスの検出及びサーベイランス
US20240148713A1 (en) Composition for treatment of anticancer drug resistance